Yoshio Tsujita

ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.

Akira Endo, Masao Kuroda, Yoshio Tsujita · The Journal of Antibiotics · 1976 · 954 citations · Full text

Life Sciences, Microbiology, Drug Discovery +2

CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species

Yoshio Tsujita, Masao Kuroda, Yoko Shimada et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 1986 · 375 citations

Life Sciences, Biochemistry, Pharmacology +14

Inhibition of Cholesterol Synthesis <i>in vitro</i> and <i>in vivo</i> by ML‐236A and ML‐236B, Competitive Inhibitors of 3‐Hydroxy‐3‐methylglutaryl‐Coenzyme A Reductase

Akira Endo, Yoshio Tsujita, Masao Kuroda et al. · European Journal of Biochemistry · 1977 · 263 citations · Full text

Life Sciences, Biochemistry, Pharmacology +14

WHHL‐Rabbit: a low density lipoprotein receptor‐deficient animal model for familial hypercholesterolemia

Kazuhiko Tanzawa, Yoko Shimada, Masao Kuroda et al. · FEBS Letters · 1980 · 190 citations · Full text

Life Sciences, Endocrinology, Lipid Biochemistry +9

Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor

Teiichiro Koga, Yohko Shimada, Masao Kuroda et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 1990 · 168 citations

Life Sciences, Biochemistry, Pharmacology +14